Anthrax Treatment Market size is poised to reach USD 2 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of anthrax treatment was USD 720 Million. The reason behind the growth is impelled by the growing population of animals across the globe owing to immigration and births, seasonal or other environmental changes, or it can be fueled by mechanisms that depend on density. For instance, the number of cattle worldwide increased from roughly 937 million in 2021 to over 920 million in 2022.
The growing awareness is believed to fuel the anthrax treatment market growth. Raising public awareness among households in remote areas has led to an increase in the ability of the workers to receive emergency medical care and recognizing the need for quick medical attention in the event of symptoms critical to the success of the anthrax treatment process.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~8% |
|
Base Year Market Size (2023) |
~ USD 720 Million |
|
Forecast Year Market Size (2036) |
~ USD 2 Billion |
|
Regional Scope |
|
Anthrax Type (Cutaneous, Inhalation, Gastrointestinal, Injection)
The Inhalation segment in the anthrax treatment market is estimated to gain a robust revenue share of 44% in the coming years owing to the growing bioterrorism. The infectious condition known as inhalation or respiratory anthrax is brought on by breathing in the bacterium's spores which is the most lethal type of the illness and frequently results in death even with therapy. Early warning signs and symptoms include Flu-like symptoms, such as sore throat, low temperature, exhaustion, and muscular pains, that last for a few hours or days, and within two to five days, a high fever, a fast heartbeat, and severe dyspnea will manifest. These symptoms could last for two or three days before seemingly disappearing for one or two days, and may then recur, causing severe dyspnea, dyspnea breathing, and shock.
The accumulation of B. anthracis spores in the lung alveoli is caused by inhaling anthrax which is more lethal and challenging to cure owing to these factors, anthrax inhalation is seen as a possible bioterrorism risk since it is the most dangerous kind, and if treatment is delayed, it can be fatal. For instance, the leading cause of death for a population that is exposed and unprotected to anthrax is inhalation, with an untreated mortality rate of more than 95%. Particularly, Inhaling anthrax nearly usually results in death without medical attention, and the mortality rate with current therapy is over 40%.
Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, E-commerce, Drug Stores)
The hospitals pharmacies segment in the anthrax treatment market is set to garner a notable revenue share shortly. The important infrastructure for preventing an anthrax attack includes hospitals and acute care medical institutions since physicians can treat anthrax patients with a variety of treatments, such as antitoxin and antibiotics which is considered important because if one healthcare worker becomes incapacitated, it might have a detrimental effect on the care of dozens or more patients.
Our in-depth analysis of the global anthrax treatment market includes the following segments:
|
Anthrax Type |
|
|
Distribution Channel |
|
|
Drug Class |
|
North American Market Forecast
Anthrax Treatment market in North America is predicted to account for the largest share of 35% by 2036 impelled by the rising spending in healthcare. This has led to an increased awareness of potential health threats from several rare disorders and has also encouraged more research and development in infectious disease treatment in the region. According to estimates, in 2021, U.S. health spending climbed by more than 2% to reach around USD 4 trillion. In addition, terrorists can strike the United States by using chemical, biological, radiological, or nuclear (CBRN) weapons, therefore along with other federal agencies, the FDA is striving to ensure that the American public has access to sufficient quantities of medications and vaccines.
APAC Market Statistics
The Asia Pacific anthrax treatment market is estimated to be the second largest, during the forecast timeframe led by the growing livestock farming. The welfare of the rural populace in India is greatly influenced by the livestock sector which is a crucial and interacting component in India's mixed farming system.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?